HOME >> BIOLOGY >> NEWS
Two projects share Lillehammer Award 2006

For the fourth time, the EUREKA Lillehammer Award 2006 is being shared by two projects, both of which have developed technologies with outstanding environmental benefits. This is the fourth time such a double award has been made ? a clear indication of the exceptional standard of the competing projects. EUREKA E! 2497 EUROENVIRON BIOMAC has devised a vastly improved method of bacterial waste water treatment capable of degrading the most toxic and difficult pollutants. EUREKA E! 2625 EUROENVIRON ECDVAT's new electrochemical dyeing process allows re-use of materials, and substantial reduction in chemicals used and in waste discharged.

The 2006 EUREKA Lillehammer Award was presented today by Mrs K. Yrvin, Norwegian Vice-Minister of Industry at the biennial EUREKA Ministerial Conference in Prague. "It's a great surprise and pleasure for us," commented ECDVAT coordinator Professor Thomas Bechtold of the University of Innsbruck in Austria. Enga Luye of the BIOMAC project, from Belair Biotech, Switzerland said: "It has been a great benefit to be part of a EUREKA project, and we are honoured to receive this award."

The EUROENVIRON BIOMAC project developed a new system for treating waste water using mixtures of bacteria in granular form, which can break down even the most toxic wastes or deal with high pollutant concentration. The new system uses 50% less energy than conventional treatment and will cost 30% less as the waste water can be treated significantly faster than before. Conventional treatment uses only a few bacterial strains and cannot always break down complex pollutant mixtures or high concentrations. The BIOMAC technology selects the best combination of bacteria for specific types of pollutants, and produces this mixture in a sufficiently large volume, while retaining the same mixture of strains. The computer-controlled system has been tested from the laboratory up to industrial scale through the EUREKA project, and is ready to upgrade existing workin
'"/>

Contact: Catherine Shiels
catherine.shiels@es.eureka.be
322-777-0969
EUREKA
9-Jun-2006


Page: 1 2

Related biology news :

1. Study projects effects of forest management in Oregons Coast Range
2. Telemedicine initiative for sub-Saharan Africa: Pilot projects proposed
3. Cutting-edge projects awarded computing time on Blue Gene/L
4. ORNL researchers, supercomputer have large roles in DOE projects
5. DOE announces $60 million in projects to accelerate scientific discovery through advanced computing
6. Innovative projects help ORNL win 3rd straight DOE Pollution Prevention Award
7. Dragon Symposium highlights success of projects
8. NIH awards $13 million for science education projects
9. UFs McKnight projects combat memory maladies
10. NIH awards nearly $30 million for research facilities improvement projects
11. NSF awards 19 new projects to better undestand genetic processes in plants of economic importance

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two projects share Lillehammer Award

(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ... Generation Biometrics Market by Application, Technology, Function & Geography ... offering. The next generation biometrics market is ... CAGR of 17.9% between 2015 and 2020 ... market. Safran SA ( France ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 To ... biometric security provider HYPR Corp. announced today the addition of ... will serve as board advisor and David Raviv ... to the team underscore HYPR Corp.,s commitment to providing the ... , Dimitri Sirota co-founded Layer 7 Technologies, a ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... applications and designed for continuous operation up to 1500 bar. The sanitary design ... efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is an ideal ...
(Date:7/29/2015)... SYDNEY , July 29, 2015 US-Australian ... NVGN ) today confirmed it is committed to progressing ... as soon as practicable and to ensure the Company ... Chief Executive Officer, Iain Ross , said the ... including the lead pre-clinical programs, discovery programs and academic ...
(Date:7/29/2015)... , July 29, 2015  AsureQuality and ... molecular testing for applications in food and primary ... battery powered real-time PCR device, the Freedom4. ... right through to the supermarket shelf for producers, ... includes involvement in animal disease control and pest ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2
Cached News: